Tom Mander has been named chief executive of the contract research organisation Domainex Ltd effective in April, succeeding Trevor Perrior who is retiring. Mr Mander joined Domainex in 2015 as chief operating officer. He has a long career in small molecule drug discovery, starting at Amersham International and including marketing and business development roles at Evotec SE and Asterand. Before joining Domainex, he directed business development in the early discovery division of Charles River Laboratories.
Domainex announced the appointment on 13 February 2020.
Copyright 2020 Evernow Publishing Ltd